SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Intelligent Bio Solutions (INBS) is trending following news of a strategic manufacturing partnership aimed at significantly reducing production costs and expanding capacity, which has driven substantial intraday stock volatility. The community is actively discussing the stock's low float and high trading volume, fueling speculation about a potential short squeeze and anticipating further upward movement as it tests key resistance levels. This partnership is seen as a crucial step for scaling their fingerprint drug screening technology ahead of anticipated future market expansion.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending due to recent discussions surrounding its integration as a fuel-discount token within the EzFill app, generating buzz about its expanding utility. The community is sharply divided, with many anticipating significant future appreciation from multi-year lows and viewing it as "digital silver," while others express frustration over its recent price action and struggle to overcome key resistance levels.

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is currently a focal point for year-end tax loss selling, leading to sharp price movements and a polarized community discussion. Many foresee further declines for the meme coin, while a resilient group of long-term holders views the current dip as a strategic accumulation opportunity for future crypto cycles, with eyes on a potential rally in 2026.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending significantly following the FDA approval of NEREUS, marking the first new pharmacologic treatment for motion-induced vomiting in over four decades. The community is actively discussing the drug's potential beyond motion sickness, particularly its vast opportunity in addressing GLP-1 induced nausea, which many see as a transformative revenue driver for the company. With analysts raising price targets and whispers of potential buyout interest, investors anticipate continued upside as the market fully prices in this key regulatory win and the company's robust pipeline.

ESH Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 17, 2021 and is headquartered in New York, NY.

ESH Acquisition Corp - Ordinary Shares - Class A

ESH Acquisition Corp (ESHA) is trending within a volatile low-float SPAC sector, fueled by discussions surrounding its extremely tight share float and high insider ownership. The community is actively debating its potential for rapid price movement and a short squeeze, drawing comparisons to other recently surging SPACs as new utility via a planned reward token is also highlighted.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics (CORT) is trending with significant volatility after receiving an FDA Complete Response Letter for its relacorilant drug, triggering a sharp decline in shares. The community is fiercely divided, with many calling the sell-off an overreaction given the company's existing profitable drug and deep pipeline, while others foresee further downside following analyst downgrades and a need for more clinical evidence. This binary regulatory event has intensified speculation, as investors weigh potential recovery against lingering uncertainty.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is trending following the FDA's acceptance and priority review of AXS-05 for Alzheimer's disease agitation, alongside positive feedback supporting an upcoming NDA for AXS-12 in narcolepsy. The market is reacting strongly to this dual pipeline advancement, with community members expressing high optimism and noting significant short-covering as a key driver of the momentum.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. Its product also includes Ogluo which is used for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is trending after a competitor's drug for Cushing's syndrome received a regulatory setback from the FDA, which the community views as a significant advantage for Xeris's approved treatment, Recorlev. This development is seen as clearing the path for Recorlev to gain market share, fueling discussions among investors about the company's long-term growth potential and undervaluation, supported by positive analyst outlooks.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is highly active following the CME Group's recent, repeated increases in margin requirements for silver futures, sparking intense debate among traders who see it as a desperate measure to control a surging market. This volatility is further fueled by conflicting narratives around impending Chinese silver export restrictions and the growing disconnect between paper and physical prices. The community is sharply divided between those predicting a massive short squeeze driven by industrial demand and global supply shifts, and those anticipating a significant pullback.

Alchemy Investments Acquisition Corp. 1 is a blank check company, which engages in merger, share exchange, asset acquisition, share purchase, and reorganization or similar business combination. The company was founded on October 27, 2021 and is headquartered in Newark, DE.

Alchemy Investments Acquisition Corp 1 - Ordinary Shares - Class A

ALCY is attracting considerable attention, primarily driven by its status as a low-float SPAC, leading to strong comparisons with other recent tickers that have seen significant, swift price movements. The community is actively discussing "dip buys" and speculating on potential upside, with many anticipating a continuation of the "low float SPAC bubble" trend while also acknowledging the inherent risks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Imperial Petroleum (NASDAQ:IMPP) Announces Earnings Results

Imperial Petroleum (NASDAQ:IMPP - Get Free Report) issued its quarterly earnings data on Thursday. The company reported $0.31 EPS for the quarter, beating the consensus estimate of $0.10 by $0.21...

Imperial Petroleum (IMPP) Expected to Announce Quarterly Earnings on Monday

Imperial Petroleum (NASDAQ:IMPP) will be releasing earnings before the market opens on Monday, December 8. (View Earnings Report at...

Wall Street Zen Downgrades Imperial Petroleum (NASDAQ:IMPP) to Hold

Wall Street Zen cut shares of Imperial Petroleum from a "buy" rating to a "hold" rating in a research report on Saturday...

<ul class="summary-bullets"><li>Imperial Petroleum stated ​​it has entered into a securities purchase agreement with two institutional investors for the sale of over 9.52 million shares of its common stock.</li><li>The Class F and Class G warrants will have an exercise price of $6.30 and will be immediately exercisable.</li><li>The company said that it currently intends to use the net proceeds from the offering for working capital and general corporate purposes.</li></ul>Imperial Petroleum (IMPP) shares fell by more than 10% in early trading on Friday after the company announced pricing for its direct registered offering.According to the company, the gross proceeds from the offering are expected to be approximately $60.0 million.Imperial Petroleum stated ​​it has entered into a securities purchase agreement with two institutional investors for the sale of over 9.52 million shares of its common stock and accompanying Class F warrants to purchase up to 9.52 million shares of common stock and Class G warrants to purchase the same quantity of common stock at a combined purchase price of $6.30 per share and accompanying warrants.<h2 class="st-heading-2">Details Of The Warrants</h2>The Class F and Class G warrants will have an exercise price of $6.30 and will be immediately exercisable. The warrants will expire five years following the date of issuance.Imperial Petroleum said that it currently intends to use the net proceeds from the offering for working capital and general corporate purposes. The company said the offering is expected to close on or about December 1.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Imperial Petroleum jumped to ‘bullish’ from ‘neutral’ territory compared to a day ago, with message volumes at ‘high’ levels, according to data from Stocktwits.A bullish user on Stocktwits expects Imperial Petroleum stock to reach $15 in a few months.<stembedurl>https://stocktwits.com/Vsunnny/message/637651021</stembedurl><a href="https://stocktwits.com/symbol/IMPP">Shares of Imperial Petroleum</a> have gained over 60% this year and 50% over the last 12 months.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/wlds-stock-gains-premarket-on-securing-57-m-through-warrant-inducement-deal/cL5aTZqRELO">WLDS Stock Gains Premarket On Securing $5.7M Through Warrant Inducement Deal</a>

Why Is IMPP Stock Down 10% Today?

Imperial Petroleum announced pricing for its direct registered offering worth $60 million.

Equity

Imperial Petroleum (NASDAQ:IMPP) Trading Up 0.8% - Still a Buy?

Imperial Petroleum (NASDAQ:IMPP) Shares Up 0.8% - What's Next...

Imperial Petroleum (IMPP) CEO&nbsp;Harry Vafias stated on Friday that, despite the second quarter being a traditionally weak period, particularly for tankers, the company managed to improve its profitability compared to the first quarter of 2025.Vafias stated on the post-earnings call that this improvement was primarily driven by increased tanker time charter coverage, which led to improved performance of its product tankers. “During the second quarter of 2025, we did witness a turbulent market in terms of geopolitical events, mainly in June, with the brief Israel-Iran War,” he said.He added that this conflict caused a spike in tanker rates and affected market sentiment due to the high risk.Retail sentiment on <a href="https://stocktwits.com/symbol/IMPP">Imperial Petroleum</a> improved to ‘extremely bullish’ from ‘bullish’ territory, with message volumes at ‘extremely high’ levels, according to data from Stocktwits.<figure class="image"><img style="aspect-ratio:805/107;" src="https://news.stocktwits-cdn.com/IMPP_sentiment_png_98466ec5b0.webp" alt="IMPP sentiment.png" width="805" height="107"><figcaption>IMPP sentiment and message volume September 5, 2025, as of 1:30 pm ET | Source: Stocktwits</figcaption></figure>Shares of Imperial Petroleum were up 2% during midday trading on Friday. The company's second-quarter revenue came in at $36.3 million, compared with Wall Street expectations of $29.70 million, according to data compiled by Fiscal AI. Its earnings per share came in at $0.35, compared with estimates of $0.04.Vafias noted that the company took delivery of seven dry bulk ships, expanding its fleet by about 56% and reaching 19 non-Chinese-built vessels.A user on Stocktwits noted that 19 vessels, operating at a profit of $13 million every three months, with no debt, “is a great business.”<stembedurl>https://stocktwits.com/Beaver_Believer12/message/627617772</stembedurl>The company noted that vessels’ operating expenses for the three months ended June 30 were $8.4 million, compared with $6.5 million for the same period a year ago. The increase in vessels’ operating expenses is primarily due to the increased size of the company’s fleet by an average of 3.8 vessels between the two periods.Imperial Petroleum’s shares have gained nearly 16% this year and have lost 17% in the last 12 months.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/roblox-testing-new-app-similar-to-tik-tok-for-sharing-video-game-play-highlights-report/chwIkwcRdqm">Roblox Testing New App Similar To TikTok For Sharing Video Game Play Highlights: Report</a>

Imperial Petroleum Earnings Call: CEO Highlights Q2 Profit Growth Amid Tanker Market Slump, Geopolitical Issues

The company's second-quarter revenue came in at $36.3 million, compared with Wall Street expectations of $29.70 million, according to data compiled by Fiscal AI.

Shares of Imperial Petroleum (IMPP) declined over 3% on Thursday after the company’s fourth-quarter <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/02/13/3025965/0/en/Imperial-Petroleum-Inc-Reports-Fourth-Quarter-and-Twelve-Months-2024-Financial-and-Operating-Results.html">earnings</a> fell short of Wall Street estimates.Revenue fell 12.4% year-over-year (YoY) to $26.2 million during the quarter, falling short of a Wall Street estimate of $37 million, according to FinChat data. The decline in revenue was primarily driven by a decrease in the spot market rates.Adjusted earnings per share (EPS) came in at $0.12 versus an analyst estimate of $0.26. Net income declined 39% YoY to $3.92 million.CEO Harry Vafias noted that market conditions in 2024 were somewhat softer than 2023 when tanker rates oscillated around all time high levels.“Nevertheless, our debt free fleet of eleven vessels managed to generate $50 million of profit and maintain an enviable cash base of $207 million. In the period ahead, our key focus is to materialize our already announced fleet growth plans and sustain our profitable momentum,” he said.During the fourth quarter, the company witnessed an almost 180% increase in time charter days compared to the same quarter a year ago, as two of its product tankers and one newly acquired bulk carrier were under time charter employment for the whole period.Drydocking costs fell to $0.2 million in Q4 compared to $2.5 million a year ago. Interest income stood at $2.3 million as compared to $2 million in the fourth quarter of 2023 while the firm reported a foreign exchange loss of $3.3 million compared to a gain of $1.4 million in the same quarter a year ago.As of Dec. 31, 2024, the company’s cash and cash equivalents, including time deposits, amounted to $206.7 million, while total bank debt amounted to nil. Interestingly, this is more than double the firm’s market capitalization.A Stocktwits user questioned why the company is not considering going private despite holding much more cash than its entire market capitalization.<stembedurl>https://stocktwits.com/Avinbird/message/604134672</stembedurl>Another user sees immense value in the firm.<stembedurl>https://stocktwits.com/akbazar/message/604131580</stembedurl><a href="https://stocktwits.com/symbol/IMPP">IMPP shares</a> have fallen below 14% in 2025 and have lost over 9% in the past year.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/blacksky-technology-stock-rallies-after-company-wins-8-figure-contract/ch5XD6mRHe">Blacksky Technology Stock Rallies After Company Wins 8-Figure Multi-Year Contracts: Retail Gets More Bullish</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Abstract digital data numbers - stock photo

This Shipping Company Holds More Cash Than Its Market Cap: Retail Sees Immense Value Despite Disappointing Earnings

During the fourth quarter, Imperial Petroleum witnessed an almost 180% increase in time charter days compared to the same quarter a year ago.

During the fourth quarter, Imperial Petroleum witnessed an almost 180% increase in time charter days compared to the same quarter a year ago, as two of its product tankers and one newly acquired bulk carrier were under time charter employment for the whole period.

Shares of Imperial Petroleum Inc ($IMPP), a company that provides petroleum products, crude oil and dry bulk seaborne transportation services, fell over 3% on Monday after the company <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2024/12/02/2989893/0/en/IMPERIAL-PETROLEUM-INC-Reports-Third-Quarter-and-Nine-Months-2024-Financial-and-Operating-Results.html">reported</a> mixed third-quarter results.Revenue rose 12% year-over-year (YoY) to $33 million during the quarter but fell short of Wall Street expectations of $35.8 million. The rise in revenue was primarily due to an increase in voyage days by 19.5% (145 days) attributed mainly to the rise of the firm’s average number of vessels along with improved revenue stemming from product tankers.Adjusted earnings per share came in at $0.32 versus an analyst estimate of $0.26. Net income fell to $10.06 million during the quarter compared to $12.12 million in the same quarter a year ago.Imperial Petroleum’s fleet operational utilization stood at 65.6% during the quarter versus 70.5% in Q3 of 2023.CEO Harry Vafias acknowledged that the market was volatile and weak during the third quarter and that it still remains an unknown how future geopolitical tensions will affect the tanker and broader shipping market overall. However, he expressed optimism on the firm’s financials.“Since the beginning of the year we have generated a net profit of close to $46 million with a fleet of about 10 vessels. Apart from our ongoing profitability, our financial strength is shown by our cash of about $200 million in conjunction with zero leverage,” he said.Retail investors on Stocktwits expressed mixed opinions on the stock.<stembedurl>https://stocktwits.com/Foch155/message/594717943</stembedurl><stembedurl>https://stocktwits.com/TheMarketMaker100/message/594685846</stembedurl><stembedurl>https://stocktwits.com/pablo_picasso_/message/594694370</stembedurl>IMPP shares have gained over 12% since the beginning of the year, significantly underperforming the benchmark indices.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/diana-shipping-stock-rallies-on-tender-offer-to-purchase-15m-shares/cJ9kYXqRhd">Diana Shipping Stock Rallies On Tender Offer To Purchase 15M Shares At $2 Apiece: Retail Sentiment Hits 1-Year High</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Adjusted earnings per share came in at $0.32 versus an analyst estimate of $0.26. | Representative Image Source: Pixabay

Imperial Petroleum Stock Falls On Mixed Q3 Earnings Report: Retail’s Undecided

Revenue rose 12% year-over-year (YoY) to $33 million during the quarter but fell short of Wall Street expectations of $35.8 million.

Imperial Petroleum, Inc. is a ship-owning company, which engages in the provision of petroleum products and crude oil seaborne transportation services. It offers international seaborne transportation services to oil producers, refineries, and commodities traders. The company has a fleet of three medium range product tankers that carry refined petroleum products, such as gasoline, diesel, fuel oil and jet fuel, as well as edible oils and chemicals, and one Aframax tanker, which is used for carrying crude oil. Imperial Petroleum was founded on May 14, 2021 and is headquartered in Athens, Greece.

IMPP
Imperial Petroleum Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest IMPP News

IMPPImperial Petroleum Inc